Discovery of novel ALK2 inhibitors of pyrazolo-pyrimidines: A computational study

References

• Ahamad, S., Hassan, M. I., & Dwivedi, N. (2018). Designing of phenol-based β-carbonic anhydrase1 inhibitors through QSAR, molecular docking, and MD simulation approach . 3 Biotech, 8(5), 256. https://doi.org/10.1007/s13205-018-1278-z
   PubMedGoogle Scholar
• Amena, A., AbuAli, O., & Abdellattif, M. (2020). Computational approaches for the designing of novel anticancer compounds based on pyrazolo[3,4-d]pyrimidine derivatives as TRAP1 inhibitor. http://gohom.win/ManualHom/Schrodinger_20152_docs/maestro/help_Maestro/phase/atom_based_qsar.html
   Google Scholar
• Asati, V., Bharti, Sk., & Budhwani, Ak. (2017). 3D-QSAR and virtual screening studies of thiazolidine-2,4-dione analogs: Validation of experimental inhibitory potencies towards PIM-1 kinase. Journal of Molecular Structure, 1133, 278–293. https://doi.org/10.1016/j.molstruc.2016.12.006
   Web of Science ®Google Scholar
• Chaikuad, A., Alfano, I., Kerr, G., Sanvitale, C. E., Boergermann, J. H., Triffitt, J. T., Delft, F. V., Knapp, S., Knaus, P., & Bullock, A. N. (2012). Structure of the bone morphogenetic protein receptor ALK2 and implications for fibrodysplasia ossificans progressiva. The Journal of Biological Chemistry, 287(44), 36990–36998. https://doi.org/10.1074/jbc.M112.365932
   PubMed Web of Science ®Google Scholar
• Clark, M., Cramer, R. D., III,., & Van Opdenbosch, N. (1989). Validation of the general purpose Tripos 5.2 force field. Journal of Computational Chemistry, 10(8), 982–1012. https://doi.org/10.1002/jcc.540100804
   Web of Science ®Google Scholar
• Crisan, L., Borota, A., Bora, A., & Pacureanu, L. (2019). Diarylthiazole and diarylimidazole selective COX-1 inhibitor analysis through pharmacophore modeling, virtual screening, and DFT-based approaches. Structural Chemistry, 30(6), 2311–2326. https://doi.org/10.1007/s11224-019-01414-w
   Web of Science ®Google Scholar
• Dixit, A., Kashaw, S. K., Gaur, S., & Saxena, A. K. (2004). Development of CoMFA, advance CoMFA and CoMSIA models in pyrroloquinazolines as thrombin receptor antagonist. Bioorganic & Medicinal Chemistry, 12(13), 3591–3598. https://doi.org/10.1016/j.bmc.2004.04.016
   PubMed Web of Science ®Google Scholar
• Dixon, S. L., Smondyrev, A. M., Knoll, E. H., Rao, S. N., Shaw, D. E., & Friesner, R. A. (2006). PHASE: A new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results . Journal of Computer-Aided Molecular Design, 20(10/11), 647–671. https://doi.org/10.1007/s10822-006-9087-6
   PubMed Web of Science ®Google Scholar
• Engers, D. W., Frist, A. Y., Lindsle, C. W., Hong, C. C., & Hopkins, C. R. (2013). Synthesis and structure-activity relationships of a novel and selective bone morphogenetic protein receptor (BMP) inhibitor derived from the pyrazolo[1.5-a]pyrimidine scaffold of dorsomorphin: The discovery of ML347 as an ALK2 versus ALK3 selective MLPCN probe. Bioorganic & Medicinal Chemistry Letters, 23(11), 3248–3252. https://doi.org/10.1016/j.bmcl.2013.03.113
   PubMed Web of Science ®Google Scholar
• Ghose, A. K., Viswanadhan, V. N., & Wendoloski, J. J. (1999). A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. Journal of Combinatorial Chemistry, 1(1), 55–68. https://doi.org/10.1021/cc9800071
   PubMedGoogle Scholar
• Golbraikh, A., & Tropsha, A. (2002). Predictive QSAR modeling based on diversity sampling of experimental datasets for the training and test set selection. Journal of Computer-Aided Molecular Design, 16(5/6), 357–369. https://doi.org/10.1023/A:1020869118689
   PubMed Web of Science ®Google Scholar
• Greco, C., Taresco, V., Pearce, A. K., Vasey, C. E., Smith, S., Rahman, R., Alexander, C., Cavanagh, R. J., Musumeci, F., & Schenone, S. (2020). Development of pyrazolo[3,4-d]pyrimidine kinase inhibitors as potential clinical candidates for glioblastoma multiforme. ACS Medicinal Chemistry Letters, 11(5), 657–663. https://doi.org/10.1021/acsmedchemlett.9b00530
   PubMed Web of Science ®Google Scholar
• Hall, M. D., Salam, N. K., Hellawell, J. L., Fales, H. M., Kensler, C. B., Ludwig, J. A., Szakács, G., Hibbs, D. E., & Gottesman, M. M. (2009). Synthesis, activity, and pharmacophore development for isatin-beta-thiosemicarbazones with selective activity toward multidrug-resistant cells. Journal of Medicinal Chemistry, 52(10), 3191–3204. https://doi.org/10.1021/jm800861c
   PubMed Web of Science ®Google Scholar
• Hatsell, S. J., Idone, V., Wolken, D. M. A., Huang, L., Kim, H. J., Wang, L., Wen, X., Nannuru, K. C., Jimenez, J., Xie, L., Das, N., Makhoul, G., Chernomorsky, R., D'Ambrosio, D., Corpina, R. A., Schoenherr, C. J., Feeley, K., Yu, P. B., Yancopoulos, G. D., Murphy, A. J., & Economides, A. N. (2015). ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A. Science Translational Medicine, 7(303), 303ra137. https://doi.org/10.1126/scitranslmed.aac4358
   PubMed Web of Science ®Google Scholar
• Jiang, J. K., Huang, X., Shamim, K., Patel, P. R., Lee, A., Wang, A. Q., Nguyen, K., Tawa, G., Cuny, G. D., Yu, P. B., Zheng, W., Xu, X., Sanderson, P., & Huang, W. (2018). Discovery of 3-(4-sulfamoylnaphthyl)pyrazolo[1,5-a]pyrimidines as potent and selective ALK2 inhibitors. Bioorganic & Medicinal Chemistry Letters, 28(20), 3356–3362. https://doi.org/10.1016/j.bmcl.2018.09.006
   PubMed Web of Science ®Google Scholar
• Jorgensen, W. L., Maxwell, D. S., & Tirado-Rives, J. (1996). Development and testing of the OPLS all atom force field on conformational en ergetics of organic liquids. Journal of the American Chemical Society, 118(45), 11225–11236. https://doi.org/10.1021/ja9621760
   Web of Science ®Google Scholar
• Kamaria, P., & Kawathekar, N. (2014). Ligand-based 3D-QSAR analysis and virtual screening in exploration of new scaffolds as Plasmodium falciparum glutathione reductase inhibitors. Medicinal Chemistry Research, 23(1), 25–23. https://doi.org/10.1007/s00044-013-0603-7
   Web of Science ®Google Scholar
• Kaushik, A. C., Kumar, S., Wei, D. Q., & Sahi, S. (2018). Structure based virtual screening studies to identify novel potential compounds for GPR142 and their relative dynamic analysis for study of Type 2 diabetes. Frontiers in Chemistry, 6, 23 https://doi.org/10.3389/fchem.2018.00023
   PubMed Web of Science ®Google Scholar
• Kirubakaran, P., Muthusamy, K., Singh, K. H., & Nagamani, S. (2012). Ligand-based pharmacophore modeling; atom-based 3D-QSAR analysis and molecular docking studies of phosphoinositide-dependent kinase-1 inhibitors. Indian Journal of Pharmaceutical Sciences, 74(2), 141–151. https://doi.org/10.4103/0250-474X.103846
   PubMed Web of Science ®Google Scholar
• Leonard, J. T., & Roy, K. (2006). On selection of training and test sets for the development of predictive QSAR models. QSAR & Combinatorial Science, 25(3), 235–251. https://doi.org/10.1002/qsar.200510161
   Google Scholar
• Ligprep, version 2.5 (2012). Schrödinger, LLC (Phase, version 4.4).
   Google Scholar
• Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 23(1–3), 3–25. https://doi.org/10.1016/S0169-409X(96)00423-1
   Web of Science ®Google Scholar
• Nickel, J., & Mueller, T. D. (2019). Specification of BMP Signaling. Cells, 8(12), 1579. https://doi.org/10.3390/cells8121579
   PubMed Web of Science ®Google Scholar
• Pacifici, M., & Shore, E. M. (2016). Common mutations in ALK2/ACVR1, a multi-faceted receptor, have roles in distinct pediatric musculoskeletal and neural orphan disorders. Cytokine & Growth Factor Reviews, 27, 93–104. https://doi.org/10.1016/j.cytogfr.2015.12.007
   PubMed Web of Science ®Google Scholar
• Phase 4.4 Quick Start Guide (2013, May). Schrödinger, LLC.
   Google Scholar
• Phase, version 4.4. (2012). Schrödinger, LLC.
   Google Scholar
• Protein preparation wizard Schrödinger, LLC (2012).
   Google Scholar
• Rajeswari, M., Santhi, N., & Bhuvaneswari, V. (2014). Pharmacophore and virtual screening of JAK3 inhibitors. Bioinformation, 10(3), 157–163. https://doi.org/10.6026/97320630010157
   PubMedGoogle Scholar
• Sallam, A. A., Houssen, W. E., Gissendanner, C. R., Orabi, K. Y., Foudah, A. I., & El Sayed, K. A. (2013). Bioguided discovery and pharmacophore modeling of the mycotoxic indole diterpene alkaloids penitrems as breast cancer proliferation, migration, and invasion inhibitors. MedChemComm, 4(10), 1360–1369. https://doi.org/10.1039/c3md00198a
   Web of Science ®Google Scholar
• Shinde, M. G., Modi, S. J., & Kulkarni, V. M. (2017). QSAR and molecular docking of phthalazine derivatives as epidermal growth factor receptor (EGFR) inhibitors. Journal of Applied Pharmaceutical Science, 7, 181–191.
   Google Scholar
• Tanwar, O. P., Saha, R., Alam, M. M., & Akhtar, M. (2012). 3D-QSAR of amino-substituted pyrido [3,2B] pyrazinones as PDE-5 inhibitors. Medicinal Chemistry Research, 21(2), 202–211. https://doi.org/10.1007/s00044-010-9523-y
   Web of Science ®Google Scholar
• Taylor, K. R., Vinci, M., Bullock, A. N., & Jones, C. (2014). ACVR1 mutations in DIPG: Lessons learned from FOP. Cancer Research, 74(17), 4565–4570. https://doi.org/10.1158/0008-5472.CAN-14-1298
   PubMed Web of Science ®Google Scholar
• Teague, S. J., Davis, A. M., Leeson, P. D., & Oprea, T. (1999). The design of leadlike combinatorial libraries. Angewandte Chemie International Edition, 38(24), 3743–3748. https://doi.org/10.1002/(SICI)1521-3773(19991216)38:24<3743::AID-ANIE3743>3.0.CO;2-U
   PubMed Web of Science ®Google Scholar
• Teli, M. K., & Rajanikant, G. K. (2012). Pharmacophore generation and atom-based 3D-QSAR of Niso - propyl pyrrole-based derivatives as HMG-CoA reductase inhibitors. Organic and Medicinal Chemistry Letters, 2, 1–10.
   PubMedGoogle Scholar
• Vogt, J., Traynor, R., & Sapkota, G. P. (2011). The specificities of small molecule inhibitors of the TGFß and BMP pathways. Cellular Signalling, 23(11), 1831–1842. https://doi.org/10.1016/j.cellsig.2011.06.019
   PubMed Web of Science ®Google Scholar
• Warren, K. E. (2012). Diffuse intrinsic pontine glioma: Poised for progress. Frontiers in Oncology, 2, 205. https://doi.org/10.3389/fonc.2012.00205
   PubMedGoogle Scholar